Scholarlink

<p>The increasing prevalence of MDR-ESKAPE pathogens, due to their resistance to conventional antibiotics, has become a serious challenge; thus, a need to explore the potential of chitosan-porphyrin composites as an alternative biomedical material. In this study, different porphyrin derivatives, including TPP, THPP, TMePP, TPPS, TCPP, and TMPyP, their metallated (Ag, Zn, and Sn) series, and chitosan-modified derivatives were evaluated for antibacterial photodynamic inactivation (aPDI) activities against some MDR bacterial pathogens under visible light irradiation using the agar well diffusion method. These MDR pathogens include <i>Pseudomonas aeruginosa </i>(<i>P. aeruginosa</i>), <i>Acinetobacter baumannii </i>(<i>A. baumannii</i>), <i>Klebsiella pneumoniae </i>(<i>K. pneumoniae</i>), <i>Enterococcus faecium </i>(<i>E. faecium</i>), and <i>Staphylococcus aureus </i>(<i>S. aureus</i>). In our results, the metallated derivatives AgTCPP, SnTHPP, and SnTMPyP showed strong aPDI activity against Gram-negative bacteria (<i>P. aeruginosa</i>,<i> A. baumannii</i>,<i> K. pneumoniae</i>). Also, AgTMPyP, SnTMPyP, and ZnTCPP inhibited <i>E. faecium</i> and <i>S. aureus</i>. For the CPCs, several CPCs exhibited antibacterial activity against <i>P. aeruginosa 1</i> (C-AgTHPP, C-AgTMePP), <i>P. aeruginosa 2</i> (C-AgTMePP, C-AgTMPyP), <i>A. baumannii</i> (C-ZnTHPP, C-SnTHPP, C-AgTMePP, C-ZnTPPS), <i>K. pneumoniae</i> (C-AgTHPP, C-ZnTHPP, C-AgTMePP), <i>E. faecium</i> (C-ZnTHPP, C-AgTMePP), and <i>S. aureus</i> (C-AgTPP, C-AgTMePP, C-ZnTPPS, C-AgTMPyP). Among the CPCs, C-AgTMePP and C-AgTMPyP demonstrated extended antibacterial activity against all test isolates. This comprehensive in vitro screening suggests the potential of CPCs as an aPDI agent against MDR-ESKAPE pathogens. Their clinical applications may offer an alternative therapeutic route to reducing the global threat of antimicrobial resistance.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Comparative screening of porphyrins and chitosan-porphyrin composites as potential antibacterial photodynamic inactivation photosensitizers against multidrug-resistant ESKAPE pathogens

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年7月24日

查看全文
  • Oluwafemi Bamidele Daramola,
  • Reama Chinedu George,
  • Afusat Ajoke Olajide,
  • Folasade Muibat Adeyemi,
  • Nkem Torimiro

摘要

The increasing prevalence of MDR-ESKAPE pathogens, due to their resistance to conventional antibiotics, has become a serious challenge; thus, a need to explore the potential of chitosan-porphyrin composites as an alternative biomedical material. In this study, different porphyrin derivatives, including TPP, THPP, TMePP, TPPS, TCPP, and TMPyP, their metallated (Ag, Zn, and Sn) series, and chitosan-modified derivatives were evaluated for antibacterial photodynamic inactivation (aPDI) activities against some MDR bacterial pathogens under visible light irradiation using the agar well diffusion method. These MDR pathogens include Pseudomonas aeruginosa (P. aeruginosa), Acinetobacter baumannii (A. baumannii), Klebsiella pneumoniae (K. pneumoniae), Enterococcus faecium (E. faecium), and Staphylococcus aureus (S. aureus). In our results, the metallated derivatives AgTCPP, SnTHPP, and SnTMPyP showed strong aPDI activity against Gram-negative bacteria (P. aeruginosa, A. baumannii, K. pneumoniae). Also, AgTMPyP, SnTMPyP, and ZnTCPP inhibited E. faecium and S. aureus. For the CPCs, several CPCs exhibited antibacterial activity against P. aeruginosa 1 (C-AgTHPP, C-AgTMePP), P. aeruginosa 2 (C-AgTMePP, C-AgTMPyP), A. baumannii (C-ZnTHPP, C-SnTHPP, C-AgTMePP, C-ZnTPPS), K. pneumoniae (C-AgTHPP, C-ZnTHPP, C-AgTMePP), E. faecium (C-ZnTHPP, C-AgTMePP), and S. aureus (C-AgTPP, C-AgTMePP, C-ZnTPPS, C-AgTMPyP). Among the CPCs, C-AgTMePP and C-AgTMPyP demonstrated extended antibacterial activity against all test isolates. This comprehensive in vitro screening suggests the potential of CPCs as an aPDI agent against MDR-ESKAPE pathogens. Their clinical applications may offer an alternative therapeutic route to reducing the global threat of antimicrobial resistance.